| 4 November 2023 | Daily rhythm in cortical chloride homeostasis underpins functional changes in visual cortex excitability
| Pracucci, E; Graham, RT; Alberio, L; et al. |
| 7 March 2023 | Demonstrating multi-country calibration of a tuberculosis model using new history matching and emulation package - hmer
| Scarponi, D; Iskauskas, A; Clark, RA; et al. |
| 5 July 2023 | Detection of genomic mutations in blood and urine free circulating tumour DNA in patients with inoperable and metastatic lung adenocarcinoma harbouring an EGFR mutation in tissue: a UK pilot study
| Brooks, H; Li, L; Addeo, A; et al. |
| 1 December 2023 | Developing consensus on core outcome sets of domains for acute, the transition from acute to chronic, recurrent/episodic, and chronic pain: results of the INTEGRATE-pain Delphi process
| Bova, G; Domenichiello, A; Letzen, JE; et al. |
| 8 May 2024 | Development of a clinical calculator to aid the identification of MODY in pediatric patients at the time of diabetes diagnosis
| Shields, B; Carlsson, A; Patel, K; et al. |
| 14 November 2022 | Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort study
| Dennis, JM; Young, KG; McGovern, AP; et al. |
| 6 May 2022 | Diagnosing Type 1 diabetes in adults: Guidance from the UK T1D Immunotherapy consortium
| Tatovic, D; Jones, AG; Evans, C; et al. |
| 7 March 2024 | Diffusion tensor imaging within the healthy cervical spinal cord: Within-participants reliability and measurement error
| Al-shaari, H; Fulford, J; Heales, CJ |
| 8 January 2024 | Dirichlet process mixture models to impute missing predictor data in counterfactual prediction models: an application to predict optimal type 2 diabetes therapy
| Cardoso, P; Dennis, JM; Bowden, J; et al. |
| 22 May 2023 | Distinct beta frequencies reflect categorical decisions
| Rassi, E; Zhang, Y; Mendoza, G; et al. |
| 27 March 2023 | Do the 'missing millions' of COPD patients want to be found?
| Halpin, DM |
| 7 August 2023 | Does physical activity moderate the association between shorter leukocyte telomere length and incident coronary heart disease? Data from 54,180 UK Biobank participants
| Xiang, M; Pilling, LC; Melzer, D; et al. |
| 7 September 2022 | Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline.
| Bourdin, A; Virchow, JC; Papi, A; et al. |
| 23 May 2023 | Dupilumab reduced severe exacerbation rates and improved pre-bronchodilator Fev 1 in patients with moderate-to-severe asthma regardless of exacerbation history of 蠅1, 蠅2, or 蠅3 prior exacerbations: Liberty Asthma Traverse
| Maspero, JF; Corren, J; Katelaris, C; et al. |
| 1 October 2022 | Dupimulab reduced exacerbations and improved lung functions in patients with moderate-to-severe asthma and prior exacerbations: Liberty Asthma Traverse study
| Corren, J; Castro, M; Maspero, JF; et al. |
